March 30, 2022
UNC-Chapel Hill scientists led by Camille Ehre, PhD, show how cells packed with SARS-CoV-2 detach from the upper airway and spread deep into lungs where severe COVID can take root. They also discovered how an asthmatic reaction to allergens battles the virus to hold severe COVID at bay.
March 22, 2022
A UNC Maternal-Fetal Medicine Network trial has shown that, among pregnant and postpartum individuals, SARS-CoV-2 infection was associated with increased risk of maternal mortality or serious morbidity from obstetric complications.
March 17, 2022
A qualitative study led by UNC School of Medicine student Lily Hale details what primary care providers and endocrine specialty clinicians reported about their patients’ self-management of diabetes during the pandemic and the effectiveness of providers’ support.
March 14, 2022
In honor of Women’s History Month, we asked our healthcare workers how they have been navigating life during the COVID-19 pandemic.
March 3, 2022
Today we are marking the completion of our second full year of living and working through the COVID-19 pandemic. We have shared this experience, but we will remember it in ways that are unique to each of us.
March 3, 2022
Hoy conmemoramos el fin de nuestro segundo año de vivir y trabajar durante la pandemia de COVID-19. Hemos compartido esta experiencia, pero cada uno de nosotros la recordará de manera única.
March 3, 2022
Masks will no longer be required in most campus spaces but will remain required in all health care settings. Research labs will follow mask requirements that were in place prior to the pandemic.
March 1, 2022
The UNC School of Medicine is reducing its enhanced distancing guidelines in non-clinical spaces, including laboratories, meeting spaces and break room spaces, to align with the University’s COVID-19 Community Standards. Masks will remain a requirement in indoor spaces on campus.
February 24, 2022
The compound CMX521 significantly reduced lung viral titer and symptoms in a SARS-CoV-2 mouse model, as reported by biomedical company Chimerix in collaboration with the Rapidly Emerging Antiviral Drug Development Initiative at UNC-Chapel Hill. UNC School of Medicine faculty Nat Moorman, PhD, and Mark Heise, PhD, are key researchers in this program.
January 31, 2022
David Wohl, MD, provides an overview of two COVID oral therapeutics, Paxlovid and Molnupiravir. We are receiving increasing supplies of these medications and want to ensure all clinicians know when it is (and isn’t) appropriate to prescribe them to help prevent hospitalization for COVID+ patients.
January 28, 2022
Lauren Raff, MD, Adult Associate Trauma Medical Director talks with the News and Observer about the latest wave of COVID-19 and how it has affected seriously-ill COVID-positive patients inside the surgical/trauma intensive care unit at UNC Medical Center.
January 26, 2022
Current therapeutic options and resources to aid appropriate selection.